Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Phenotype C0034150|purpura
Sentences 3
PubMedID- 24621321 The ifn-α treatment is considered an immune-modulator and increases the risk for immune thrombocytopenia purpura in patients with hepatitis c [10], but the mechanism of ifn-induced autoimmune thrombocytopenia is unclear [10].
PubMedID- 23888238 Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis c successfully treated with rituximab.
PubMedID- 25209590 However, clinical use of eltrombopag later confirmed that it is a safe and effective drug for immune thrombocytopenic purpura or thrombocytopenia associated with hepatitis c virus infection.

Page: 1